Nelly Mugo, MBChB, MMed, MPH

Research Associate Professor, Global Health

Prof. Nelly R. Mugo is an associate research professor in the Department of Global Health at the University of Washington, a senior principal clinical research scientist at the Kenya Medical Research Institute (KEMRI), and a reproductive health specialist with three decades of work experience. Her research focus has been on the prevention of HIV and cervical cancer among other reproductive health research work.  She has been an investigator on two landmark clinical trials, the Partners PrEP study that contributed evidence to inform the change of indication for use of Truvada as HIV prevention pre-exposure prophylaxis (PrEP) and a protocol lead for the ongoing ‘Kenya Single-dose HPV Vaccine-Efficacy (KEN SHE) Study –’ that has provided evidence on the efficacy of single-dose HPV vaccination. She is a member of the International Papillomavirus Society education committee, and the Kenya Obstetrics and Genecology society and has contributed to several World Health Organization and Kenya ministry of health working group scientific committees. She is widely published in peer review journals.

Publications

  1. Lawore, DC, Jena, S, Berard, AR, Birse, K, Lamont, A, Mackelprang, RD et al.. Computational microbiome pharmacology analysis elucidates the anti-cancer potential of vaginal microbes and metabolites. Front Microbiol. 2025;16 :1602217. doi: 10.3389/fmicb.2025.1602217. PubMed PMID:41035891 PubMed Central PMC12479523.
  2. Mugwanya, KK, Saina, M, Mugo, NR, MaWhinney, S, Morrow, M, Schaafsma, TT et al.. Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study. PLoS Med. 2025;22 (9):e1004732. doi: 10.1371/journal.pmed.1004732. PubMed PMID:40924774 PubMed Central PMC12435667.
  3. Adhiambo, HF, Owidi, E, Okello, P, Coe, M, Shin, MB, Oluoch, LM et al.. Barriers and facilitators to implementing a single-visit, screen-and-treat approach with thermal ablation for cervical cancer prevention in Kenya. PLOS Glob Public Health. 2025;5 (9):e0005166. doi: 10.1371/journal.pgph.0005166. PubMed PMID:40924765 PubMed Central PMC12419645.
  4. Jena, S, Lawore, D, Briones, JM, Birse, K, Lamont, A, Mackelprang, RD et al.. Identifying a Vaginal Microbiome-Derived Selective Antibiotic Metabolite via Microbiome Pharmacology Analysis. bioRxiv. 2025; :. doi: 10.1101/2025.08.28.672927. PubMed PMID:40909525 PubMed Central PMC12407940.
  5. Golubchik, T, Abeler-Dörner, L, Hall, M, Wymant, C, Bonsall, D, Macintyre-Cockett, G et al.. HIV-phyloTSI: subtype-independent estimation of time since HIV-1 infection for cross-sectional measures of population incidence using deep sequence data. BMC Bioinformatics. 2025;26 (1):212. doi: 10.1186/s12859-025-06189-y. PubMed PMID:40813968 PubMed Central PMC12351810.
Search PubMed

Comments are closed.